It has been illustrated that metabolic syndrome (MetS) is associated with Alzheimer disease
(AD) neuropathology. Components of MetS including central obesity, hypertension, insulin …

Metabolic syndrome (MetS), which is characterized by insulin resistance, high blood
glucose, obesity, and dyslipidemia, is known to increase the risk of dementia accompanied …

Metabolic syndrome (MetS), a cluster of metabolic conditions that include obesity,
hyperlipidemia, and insulin resistance, increases the risk of several aging-related brain …

In addition to extracellular amyloid plaques, intracellular neurofibrillary tau tangles, and
inflammation, cognitive and emotional affect perturbations are characteristic of Alzheimer's …

Abstract This Preface introduces the Special Issue entitled,“Energy Substrates and
Microbiome Govern Brain Bioenergetics and Cognitive Function with Aging”, which is …

Obesity reduces or increases the risk of developing Alzheimer's disease (AD) depending on
whether it is assessed in mid-life or late-life. There is currently no consensus on the …